GW Researchers Launch the First Basket Phase I Clinical Trial on Two Ultra-Rare Mitochondrial Diseases
September 15, 2023
Anne Chiaramello, PhD, founding director the Mito-EpiGen Program at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) received FDA approval for the first basket clinical trial in the US for two ultra-rare inherited mitochondrial diseases, MELAS and LHON-Plus.
May 16, 2023
Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.
Hematology and Oncology Fellow Fayez Estephan, MD, Awarded the 2022 The Albert L. and Elizabeth T. Tucker Postdoctoral Fellowship to Pursue Research at GW Cancer Center
January 29, 2023
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the selection of Hematology and Oncology Fellow Fayez Estephan, MD, as the 2022 recipient of the Albert L. and Elizabeth T. Tucker Postdoctoral Fellowship for his research project titled, “Her-2…
Vsevolod “Seva” Polotsky, MD, to Serve as Vice Chair for Research in the GW Depart-ment of Anesthesiology and Critical Care Medicine
December 20, 2022
Vsevolod “Seva” Polotsky, MD, has been selected to serve as vice chair for research in the Department of Anesthesiology and Critical Care Medicine at the George Washington University (GW) School of Medicine and Health Sciences and the GW Medical Faculty Associates. Polotsky will also serve as…
December 8, 2022
The George Washington University’s Institute for Biomedical Sciences (IBS) recently recognized and celebrated its Class of 2022 PhD graduates.
December 7, 2022
The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1…
November 21, 2022
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of…
September 15, 2022
The Department of Dermatology at the George Washington University School of Medicine and Health Sciences received two awards from dermatology company Galderma to establish a research fund and a medical student research fellowship.
August 9, 2022
A research team led by Jonathan Silverberg, MD, PhD, MPH, professor of dermatology at the George Washington University School of Medicine and Health Sciences, has identified which acute symptom clusters may lead to long-term, chronic infection and which individuals are most likely to develop Long…
GW Researchers Figure Out How Our Brains Enable Us to Prefer Social Interactions and What Underlies "Social Avoidance" in Rett Syndrome
July 18, 2022
A team of researchers from the George Washington University has now shown how a particular part of the brain called the medial prefrontal cortex enables mice to choose to interact with a fellow mouse instead of an inanimate object. Stimulating this part of the brain in a mouse model of Rett…